BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22846740)

  • 1. Genetic testing by cancer site: skin.
    Gabree M; Seidel M
    Cancer J; 2012; 18(4):372-80. PubMed ID: 22846740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons from the skin--cutaneous features of familial cancer.
    Winship IM; Dudding TE
    Lancet Oncol; 2008 May; 9(5):462-72. PubMed ID: 18452857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic testing by cancer site: urinary tract.
    Chan-Smutko G
    Cancer J; 2012; 18(4):343-9. PubMed ID: 22846736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of familial melanoma and nonmelanoma skin cancer syndromes.
    Santillan AA; Cherpelis BS; Glass LF; Sondak VK
    Surg Oncol Clin N Am; 2009 Jan; 18(1):73-98, viii. PubMed ID: 19056043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated genodermatoses: skin neoplasms as clues to hereditary tumor syndromes.
    Ponti G; Pellacani G; Seidenari S; Pollio A; Muscatello U; Tomasi A
    Crit Rev Oncol Hematol; 2013 Mar; 85(3):239-56. PubMed ID: 22823951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted therapy for hereditary cancer syndromes: neurofibromatosis type 1, neurofibromatosis type 2, and Gorlin syndrome.
    Agarwal R; Liebe S; Turski ML; Vidwans SJ; Janku F; Garrido-Laguna I; Munoz J; Schwab R; Rodon J; Kurzrock R; Subbiah V;
    Discov Med; 2014 Dec; 18(101):323-30. PubMed ID: 25549703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated genodermatoses: a personal history.
    Burgdorf WH
    Exp Dermatol; 2006 Sep; 15(9):653-66. PubMed ID: 16881962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic testing by cancer site: uterus.
    Daniels MS
    Cancer J; 2012; 18(4):338-42. PubMed ID: 22846735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary cancer syndromes of the skin.
    Somoano B; Niendorf KB; Tsao H
    Clin Dermatol; 2005; 23(1):85-106. PubMed ID: 15708293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial aggregation of malignant melanoma/dysplastic naevi and tumours of the nervous system: an original syndrome of tumour proneness.
    Bahuau M; Vidaud D; Kujas M; Palangié A; Assouline B; Chaignaud-Lebreton M; Prieur M; Vidaud M; Harpey JP; Lafourcade J; Caille B
    Ann Genet; 1997; 40(2):78-91. PubMed ID: 9259954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular genetics of familial tumour syndromes of the central nervous system].
    Murnyák B; Szepesi R; Hortobágyi T
    Orv Hetil; 2015 Feb; 156(5):171-7. PubMed ID: 25618858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary genodermatoses with cancer predisposition.
    Gerstenblith MR; Goldstein AM; Tucker MA
    Hematol Oncol Clin North Am; 2010 Oct; 24(5):885-906. PubMed ID: 20816579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial neurogenic tumor syndromes.
    Kimmelman A; Liang BC
    Hematol Oncol Clin North Am; 2001 Dec; 15(6):1073-84. PubMed ID: 11770299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic testing in hereditary melanoma.
    Tsao H; Niendorf K
    J Am Acad Dermatol; 2004 Nov; 51(5):803-8. PubMed ID: 15523363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Counseling for Neurofibromatosis 1, Neurofibromatosis 2, and Schwannomatosis-Practice Resource of the National Society of Genetic Counselors.
    Radtke HB; Bergner AL; Goetsch AL; McGowan C; Panzer K; Cannon A
    J Genet Couns; 2020 Oct; 29(5):692-714. PubMed ID: 32602153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The syndrome of hereditary leiomyomatosis and renal cell cancer (HLRCC): The clinical features of an individual with a fumarate hydratase gene mutation.
    Varol A; Stapleton K; Roscioli T
    Australas J Dermatol; 2006 Nov; 47(4):274-6. PubMed ID: 17034471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Histologic diagnosis of "B-K-mole Syndrome". Familial melanoma and atypical disseminated pigmentation].
    Hundeiker M
    Pathologe; 1980 May; 1(3):164-6. PubMed ID: 7454689
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic skin diseases predisposing to basal cell carcinoma.
    Castori M; Morrone A; Kanitakis J; Grammatico P
    Eur J Dermatol; 2012; 22(3):299-309. PubMed ID: 22391625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
    Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS
    Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.